-+ 0.00%
-+ 0.00%
-+ 0.00%

ARCTURUS THERAPEUTICS TO PRESENT ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY PHASE 2 CLINICAL DATA AND PROVIDE UPDATE ON MRNA LIVER THERAPEUTICS PLATFORM

Reuters·09/18/2026 13:00:01

Please log in to view news